539 |
State-of-the-Art in High Resolution IVUS |
Akiko Maehara |
Apr. 21. 15 |
538 |
Will Combined IVUS-NIRS Imaging Improve Our Ability to Predict Culprit Lesions? |
James E. Muller |
Apr. 21. 15 |
537 |
OCT: Pre- and Post-Intervention |
Takashi Kubo |
Apr. 21. 15 |
536 |
IVUS: Pre- and Post-Intervention |
Gary S. Mintz |
Apr. 21. 15 |
535 |
How to Assess Biological Activity of Inflammarory Plaque?: Combined OFDI-NIRF Molecular Imaging |
Jin Won Kim |
Apr. 21. 15 |
534 |
Procedural and Follow-up Assessment of BVS by Multimodal Imaging |
Yoshinobu Onuma |
Apr. 21. 15 |
533 |
Clinical Trials by Using NIRS: Clinical Relevance and Prognostic Implication |
Akiko Maehara |
Apr. 21. 15 |
532 |
The Unique Advantages of High Definition IVUS |
Gary S. Mintz |
Apr. 21. 15 |
531 |
Limitations of Current Imaging Modalities: Why Do We Need More? |
John McB. Hodgson |
Apr. 21. 15 |
530 |
What Happened in Deferred Lesion: Insight from IRIS-FFR Registry |
Seung-Jung Park |
Apr. 21. 15 |